Home / Reuters: U.S. / New York accuses Insys of deceptively marketing opioid

New York accuses Insys of deceptively marketing opioid

shada
(Reuters) - Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses.


from Reuters: U.S. http://ift.tt/2nsXAMV
New York accuses Insys of deceptively marketing opioid New York accuses Insys of deceptively marketing opioid Reviewed by shada on February 02, 2018 Rating: 5